318 related articles for article (PubMed ID: 9160742)
1. Deadly conformations--protein misfolding in prion disease.
Horwich AL; Weissman JS
Cell; 1997 May; 89(4):499-510. PubMed ID: 9160742
[No Abstract] [Full Text] [Related]
2. [Molecular pathogenesis of spongiform encephalopathy].
Aguzzi A; Maddalena A; Brandner S; Klein M
Pathologica; 1997 Oct; 89(5):481-90. PubMed ID: 9489393
[No Abstract] [Full Text] [Related]
3. Prion propagation and molecular chaperones.
Zahn R
Q Rev Biophys; 1999 Nov; 32(4):309-70. PubMed ID: 11194568
[No Abstract] [Full Text] [Related]
4. The state of the prion.
Weissmann C
Nat Rev Microbiol; 2004 Nov; 2(11):861-71. PubMed ID: 15494743
[TBL] [Abstract][Full Text] [Related]
5. Why are prion diseases precluded by non-mammals?
Ji HF; Zhang HY; Chen LL
Trends Biochem Sci; 2007 May; 32(5):206-8; discussion 208. PubMed ID: 17419063
[No Abstract] [Full Text] [Related]
6. [Prions].
Wieland S; von Weizsäcker F; Blum HE
Dtsch Med Wochenschr; 1996 Jul; 121(30):949-52. PubMed ID: 8765704
[No Abstract] [Full Text] [Related]
7. A general model of prion strains and their pathogenicity.
Collinge J; Clarke AR
Science; 2007 Nov; 318(5852):930-6. PubMed ID: 17991853
[TBL] [Abstract][Full Text] [Related]
8. Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.
Kellershohn N; Laurent M
Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):539-45. PubMed ID: 9729459
[TBL] [Abstract][Full Text] [Related]
9. Prion protein biology.
Prusiner SB; Scott MR; DeArmond SJ; Cohen FE
Cell; 1998 May; 93(3):337-48. PubMed ID: 9590169
[No Abstract] [Full Text] [Related]
10. Neurotoxic species in prion disease: a role for PrP isoforms?
Harrison CF; Barnham KJ; Hill AF
J Neurochem; 2007 Dec; 103(5):1709-20. PubMed ID: 17944867
[TBL] [Abstract][Full Text] [Related]
11. Loss of functional prion protein: a role in prion disorders?
Borchelt DR; Sisodia SS
Chem Biol; 1996 Aug; 3(8):619-21. PubMed ID: 8807894
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous conformational change within the prion protein--implications for disease pathogenesis?
Jackson GS
Bioessays; 2001 Sep; 23(9):772-4. PubMed ID: 11536289
[TBL] [Abstract][Full Text] [Related]
13. Prion diseases. Yielding under the strain.
Weissmann C
Nature; 1995 Jun; 375(6533):628-9. PubMed ID: 7791890
[No Abstract] [Full Text] [Related]
14. [Prions--a new class of infectious disease causative agents].
Zuev VA
Antibiot Khimioter; 1999; 44(10):33-8. PubMed ID: 10635420
[No Abstract] [Full Text] [Related]
15. The Ninth Datta Lecture. Molecular biology of transmissible spongiform encephalopathies.
Weissmann C
FEBS Lett; 1996 Jun; 389(1):3-11. PubMed ID: 8682199
[TBL] [Abstract][Full Text] [Related]
16. Prion diseases and the central dogma of molecular biology.
Hunter N
Trends Microbiol; 1999 Jul; 7(7):265-6. PubMed ID: 10390630
[No Abstract] [Full Text] [Related]
17. A transmembrane form of the prion protein in neurodegenerative disease.
Hegde RS; Mastrianni JA; Scott MR; DeFea KA; Tremblay P; Torchia M; DeArmond SJ; Prusiner SB; Lingappa VR
Science; 1998 Feb; 279(5352):827-34. PubMed ID: 9452375
[TBL] [Abstract][Full Text] [Related]
18. Insights into prion strains and neurotoxicity.
Aguzzi A; Heikenwalder M; Polymenidou M
Nat Rev Mol Cell Biol; 2007 Jul; 8(7):552-61. PubMed ID: 17585315
[TBL] [Abstract][Full Text] [Related]
19. Prion protein diversity and disease in the transmissible spongiform encephalopathies.
Priola SA
Adv Protein Chem; 2001; 57():1-27. PubMed ID: 11447687
[No Abstract] [Full Text] [Related]
20. Generating a prion with bacterially expressed recombinant prion protein.
Wang F; Wang X; Yuan CG; Ma J
Science; 2010 Feb; 327(5969):1132-5. PubMed ID: 20110469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
